Abstract
There is currently no standard practice for the monitoring of patients receiving treatment for osteoporosis. Repeated dual-energy X-ray absorptiometry (DXA) is commonly used for monitoring treatment response, but it has its limitations. Bone turnover markers have advantages over DXA as they are non-invasive, relatively cheap and can detect changes in bone turnover rates earlier. However, they do have disadvantages, particularly high within- and between-patient variability. The ability of bone turnover markers to identify treatment non-responders and predict future fracture risk has yet to be established.
Original language | English |
---|---|
Pages (from-to) | 1-180 |
Number of pages | 180 |
Journal | Health technology assessment |
Volume | 18 |
Issue number | 11 |
DOIs | |
Publication status | Published - Feb 2014 |